Form 4: VNRX CSO Micallef Settles RSUs, Tax Withholding

VolitionRx Chief Scientific Officer Jacob Vincent Micallef reported a transaction involving the withholding of 5,310 common shares to cover tax obligations from restricted stock unit settlement.

Summary

• Jacob Vincent Micallef, Chief Scientific Officer of VolitionRx Ltd. (VNRX), reported a transaction on March 17, 2026.
• The transaction involved the disposition of 5,310 shares of common stock at a price of $0.19 per share.
• This disposition was for the purpose of satisfying tax withholding obligations upon the settlement of 11,800 restricted stock units.
• No shares were sold by the reporting person or VolitionRx in this transaction.
• Following this transaction, Micallef directly beneficially owns 572,179 shares of common stock.
• Indirect beneficial ownership includes 55,000 shares by spouse and 38,113 shares by Borlaug Limited, where Micallef is a controlling director with voting and dispositive control.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine administrative transaction for tax withholding related to executive compensation rather than a strategic move or a change in the insider's investment thesis.

Positives

• The transaction was a tax withholding event, not a direct sale of shares by the insider, indicating no active divestment of equity.

Negatives

• No direct negatives identified from this routine tax withholding transaction.

Risks

• NA

Future Outlook

NA

Management Comments

• NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly Form 4 filings for RSU settlements and tax withholdings, are common occurrences for executives in publicly traded companies. This type of transaction is a routine administrative event and typically does not signal a change in company fundamentals or strategic direction, unlike open market sales or purchases.

Comparison to Industry Standards

• This is a standard Form 4 filing for tax withholding upon RSU vesting, a common practice across industries for executive compensation. Companies like Apple (AAPL) or Microsoft (MSFT) executives also routinely file Form 4s for similar tax-related dispositions of shares upon vesting of equity awards. The specific number of shares or value is relative to the individual's compensation package and the company's stock price at the time of vesting.

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• Indirect beneficial ownership of 38,113 shares of common stock is held by Borlaug Limited, where the reporting person, Jacob Vincent Micallef, is a controlling director with voting and dispositive control.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax withholding, not an open market sale.
• Employees: No direct impact.

Next Steps

• NA

Key Dates

Recommendation

This Form 4 filing details a routine tax withholding transaction related to the settlement of restricted stock units for a company executive. It does not indicate any fundamental change in the company's operations, financial health, or strategic direction, nor does it suggest a significant shift in the insider's confidence. Therefore, a "hold" recommendation is appropriate as this event provides no new information to warrant a change in investment stance.

Keywords

VNRX, VolitionRx, Jacob Vincent Micallef, Form 4, insider transaction, restricted stock units, RSU, tax withholding, beneficial ownership, Chief Scientific Officer